Sivers Semiconductors: Analysts See Upside to 2027 as $1.2 Billion Pipeline Collides With a Bruised Share Price

The Swedish photonics group Sivers Semiconductors has spent the past week navigating two very different currents: a fresh wave of analyst optimism anchored to its Glasgow manufacturing ambitions, and a share price that remains deep in the red despite a sharp post-earnings bounce.

Equity researchers handed the stock a Buy rating on Friday, arguing that the valuation reset following a 78 percent decline from earlier peaks has created a compelling entry point for investors willing to wait out the company’s transition. The investment case hinges on 2027 — the year management expects its $30 million expansion of indium phosphide production in Scotland to finally translate into meaningful revenue.

On current numbers, the stock looks anything but cheap. Based on the company’s overall business, Sivers trades at roughly 26 times enterprise value-to-sales; isolate the photonics segment and that multiple balloons to around 110 times. Analysts acknowledge the optics look demanding but point out they reflect a revenue base that has yet to scale. Should the photonics division reach approximately $30 million in sales by 2027, they estimate the share price carries 1.5 to 2 times upside potential. Most of that growth, however, is expected to land in the second half of that year, leaving nearer-term catalysts thin on the ground.

Glasgow Expansion Takes Center Stage

The production ramp in Glasgow forms the backbone of the growth narrative. Sivers is investing $30 million to lift annual capacity to more than 100 million continuously operated distributed feedback (DFB) lasers, with construction slated to begin in the second half of 2026 and operations coming online in the fourth quarter of 2027. The company is simultaneously shifting toward a hybrid manufacturing model, responding to demand from AI data centers that increasingly require higher-performance optical components.

Progress is already visible in the operational numbers. Product revenue rose 18 percent year-on-year in the second quarter on a currency-adjusted basis, and the order pipeline stood at $1.2 billion as of late July. That backlog figure represents a 268 percent jump from December 2025, a surge driven in part by a partnership with GlobalFoundries — struck roughly three months ago — to develop silicon photonics solutions for AI infrastructure. Additional contributors include a production order from ALL.SPACE worth $8.2 million for Ka-band beamforming ICs, a $3 million contract from Tachyon Networks, and $3.4 million from SemiNex. First beta production runs are also scheduled to take shape at Jabil in the fourth quarter of 2026, marking a key step toward series maturity.

Management has been candid that the pivot from development-driven NRE revenue toward scalable product sales is weighing on near-term financials. The deliberate reallocation of resources toward upcoming production launches, alongside a scaling back of NRE activities, has pressured short-term results — a trade-off the company says is intentional.

Should investors sell immediately? Or is it worth buying Sivers Semiconductors?

A Stock Caught Between Momentum and Gravity

The market’s reaction to the pipeline disclosure was initially enthusiastic. Shares climbed 24.2 percent following the announcement, with the stock closing Thursday at EUR 2.41. By Friday, it had edged up further to EUR 2.43. Yet the longer-term picture remains strained: the stock is still down 22 percent over the past month and trades roughly 29 percent below its 50-day moving average of EUR 3.44.

That disconnect underscores a broader tension. While the pipeline news offered a tangible sign of commercial traction, investors have also had to digest a summer of structural change. Around two months ago, lender Bootstrap Europe exercised its conversion rights on an outstanding convertible loan, converting $12 million of debt into equity. The move reduced leverage but diluted existing shareholders — an overhang that has periodically weighed on the share price.

Insider activity has offered a counter-signal. Vickram Vathulya, the company’s president and CEO, purchased 70,000 additional shares in July, lifting his total holding to 4,540,076 shares — a vote of confidence that some market participants have read as meaningful given the timing.

The Long Road to Proof

For now, the investment thesis remains tightly bound to a specific timeline. The next checkpoint arrives November 26, when Sivers is scheduled to report third-quarter results. That report will offer an early read on whether the $1.2 billion pipeline is converting into revenue-generating orders — and whether the elevated volatility, which has reached an annualized 160 percent over the past year, begins to subside.

Analysts argue the recent upgrade provides a framework for patient investors, but the underlying reality is that the company’s true test comes later. A visible revenue inflection is not expected before the fourth quarter of 2026, with the full impact of the Glasgow ramp landing only in 2027. Until then, shareholders must contend with a stock that has already demonstrated its capacity for sharp moves in both directions — and a growth story that remains, for now, largely a promise of what is to come.